antibody-conjugated myostatin-targeting siRNA (Avidity Biosciences)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantibody-conjugated myostatin-targeting siRNA (Avidity Biosciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionGrowth/differentiation factor 8 inhibitors
TargetsGrowth/differentiation factor 8
Therapy Area/IndicationsMuscular Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAvidity Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvidity Biosciences Inc
Active IndicationsN/A
Inactive IndicationsMuscular Atrophy

Other Information

ATC CodeN/A
Related LinksN/A